微流控组件市场 - 全球产业规模、份额、趋势、机会和预测，按产品、产业、地区和竞争细分，2020-2030 年

2024 年全球微流体组件市场价值为 54 亿美元，预计到 2030 年将达到 91 亿美元，预测期内复合年增长率为 9.29%。近年来，受医疗保健、生命科学和分析测试行业进步的推动，全球微流体组件市场经历了显着增长。微流体技术是一门操纵少量流体的科学和技术，为各领域的创新解决方案铺平了道路。微流体元件是微流体设备的基本组成部分，旨在微尺度上处理少量流体。这些组件包括微流控晶片、帮浦、阀门、连接器、感测器和其他配件。微流体元件的应用涵盖医疗保健、製药、生物技术和诊断等各个产业。

市场概况
预测期	2026-2030
2024 年市场规模	54 亿美元
2030 年市场规模	91亿美元
2025-2030 年复合年增长率	9.29％
成长最快的领域	微型针
最大的市场	北美洲

实验室和护理点对小型化和自动化系统的需求是微流体组件市场的主要驱动力。小型化可以经济高效地处理少量样本，减少试剂消耗并改善整体工作流程。微流体元件在各种生物医学应用中发挥着至关重要的作用，例如细胞分析、DNA 定序和即时诊断。进行小规模复杂生物和化学分析的能力推动了个人化医疗和快速疾病检测的进步。研发活动资金的增加，特别是生命科学和医疗保健领域的研发资金，推动了新型微流体技术的发展。这导致了创新产品和解决方案的产生，推动了市场成长。快速现场诊断的需求激增，导致对即时诊断设备中微流体组件的需求增加。这些设备提供即时结果，从而能够及时进行医疗干预并改善患者的治疗效果。

主要市场驱动因素

即时诊断需求不断成长

环境监测领域的日益普及推动了全球微流体元件市场的发展

主要市场挑战

成本和可扩展性

主要市场趋势

技术进步

分段洞察

产品洞察

产业洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第四章：全球微流控组件市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（阀门（电磁阀、流量控制阀、止回阀、梭阀、洩压阀、比例阀、其他阀门）、流量和压力控制器、流量和压力感测器、微型帮浦、喷嘴、微针、其他）
  • 按行业（石油和天然气、医疗保健、航太和国防、消费性电子、汽车、其他行业）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按产品
  • 按行业
  • 按地区

第五章：亚太地区微流控元件市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按行业
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲微流体组件市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按行业
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 7 章：北美微流控组件市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按行业
  • 按国家
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 8 章：南美洲微流控组件市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按行业
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 9 章：中东和非洲微流控组件市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按行业
  • 按国家
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 埃及

第 10 章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 12 章：全球微流体组件市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Parker Hannifin Corporation
• IDEX Corporation
• Fluigent SA
• Staiger GmbH & Co. KG
• SMC Corporation
• Camozzi Automation Spa Societa Unipersonale
• Aignep spa
• FIM Valvole Srl
• Humphrey Products Corporation
• Dolomite Microfluidics
• Cellix Ltd.
• Christian Burkert GmbH & Co. KG

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Microfluidic Components Market was valued at USD 5.40 Billion in 2024 and is expected to reach USD 9.10 Billion by 2030 with a CAGR of 9.29% during the forecast period. The global microfluidic components market has been experiencing remarkable growth in recent years, driven by advancements in healthcare, life sciences, and analytical testing industries. Microfluidics, the science and technology of manipulating small amounts of fluids, has paved the way for innovative solutions in various fields. Microfluidic components refer to the essential building blocks of microfluidic devices, which are designed to handle small volumes of fluids at the microscale level. These components include microfluidic chips, pumps, valves, connectors, sensors, and other accessories. The applications of microfluidic components span across diverse industries, including healthcare, pharmaceuticals, biotechnology, and diagnostics.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 5.40 Billion
Market Size 2030	USD 9.10 Billion
CAGR 2025-2030	9.29%
Fastest Growing Segment	Microneedles
Largest Market	North America

The demand for miniaturized and automated systems in laboratories and point-of-care settings is a major driver for the microfluidic components market. Miniaturization allows for cost-effective and efficient handling of small sample volumes, reducing reagent consumption and improving overall workflow. Microfluidic components play a crucial role in various biomedical applications, such as cell analysis, DNA sequencing, and point-of-care diagnostics. The ability to perform complex biological and chemical analyses on a small scale has led to advancements in personalized medicine and rapid disease detection. Increased funding for research and development activities, particularly in the life sciences and healthcare sectors, has fueled the development of new microfluidic technologies. This has resulted in the creation of innovative products and solutions, driving market growth. The need for rapid and on-site diagnostics has surged, leading to an increased demand for microfluidic components in point-of-care testing devices. These devices offer real-time results, enabling timely medical interventions and improving patient outcomes.

Key Market Drivers

Rising Demand for Point-of-Care Diagnostics

In recent years, the field of healthcare has witnessed a transformative shift towards personalized and on-the-spot diagnostics, leading to a significant surge in the demand for point-of-care (POC) diagnostics. This paradigm shift is driving the global microfluidic components market, as microfluidic technology plays a pivotal role in enabling precise and rapid diagnostic processes. The integration of microfluidics in diagnostic devices has not only enhanced the speed and accuracy of testing but has also opened up new possibilities for portable and user-friendly healthcare solutions. Point-of-care diagnostics refer to medical tests conducted near the patient, often at the bedside or in a clinical setting, providing rapid results without the need for centralized laboratory facilities. Integrated microfluidic sensors have transformed diagnostics by merging precision engineering, fluid dynamics, and biochemical analysis into compact, cost-effective devices. These lab-on-a-chip (LOC) technologies facilitate real-time monitoring, quick analysis, and high sensitivity, making them vital for point-of-care (POC) diagnostics. Leading companies like Abbott Laboratories, Fluidigm, and Dolomite Microfluidics are pioneers in developing innovative microfluidic systems. These systems improve laboratory efficiency by consolidating complex processes onto a single chip. For example, Fluidigm's Biomark HD platform enables high-throughput gene expression analysis across multiple samples, while Abbott Laboratories has advanced rapid, accurate testing using microfluidic technology. Dolomite Microfluidics specializes in custom tools for applications ranging from drug discovery to environmental monitoring, offering precise fluid control for various analytical tasks. These companies are driving innovation in genomics, diagnostics, and biomedical research.

POC diagnostics enable healthcare providers to make swift and informed decisions, leading to timely patient care and treatment. Rapid diagnostic results are crucial in emergency situations and can significantly impact patient outcomes. Traditional laboratory-based tests may have longer turnaround times, leading to delays in diagnosis and treatment. POC diagnostics, powered by microfluidic components, offer quick results, allowing for immediate intervention and personalized patient care. POC diagnostics enhance accessibility to healthcare, particularly in resource-limited or remote areas where access to centralized laboratories is challenging. Portable and handheld devices equipped with microfluidic components bring diagnostics closer to the patient. The ease of use and quick results provided by microfluidic POC devices facilitate more frequent and convenient preventive screenings. This can aid in the early detection of diseases, leading to better management and improved health outcomes.

Growing Adoption in Environmental Monitoring is Driving the Global Microfluidic Components Market

The global microfluidic components market is experiencing a significant surge in demand, propelled by the growing adoption of microfluidic technology in environmental monitoring applications. Microfluidics involves the manipulation of small volumes of fluids on a microscale, enabling precise control and analysis of various chemical and biological processes. This technology has found extensive applications in environmental monitoring, contributing to the burgeoning market for microfluidic components. The 21st century has witnessed an unprecedented increase in environmental challenges, including climate change, pollution, and depletion of natural resources. Governments, industries, and research institutions worldwide are increasingly recognizing the importance of monitoring and managing environmental parameters to mitigate the impact of these challenges. Microfluidic technology has emerged as a powerful tool for achieving accurate and real-time environmental monitoring.

The growing adoption of microfluidic components in environmental monitoring is being driven by the increasing need to detect and analyze pollutants, such as heavy metals (e.g., chromium, lead, mercury, arsenic, and cadmium), which pose significant risks to ecosystems and human health. These metals can bioaccumulate in plants and animals, impacting the food chain. In August 2024, researchers in Sweden developed an advanced method to accelerate the separation of particles in fluids, offering new opportunities for monitoring environmental contaminants like microplastics in drinking water. The technique, outlined by scientists at KTH Royal Institute of Technology, enhances particle control using elasto-inertial microfluidics, a process that leverages the elastic properties of fluids and dynamic forces to achieve faster and more accurate results. This breakthrough underscores the growing role of microfluidic technologies in environmental analysis, further driving demand for microfluidic components in the global market. Microfluidic components enable the miniaturization of analytical devices, making them portable and suitable for on-site environmental monitoring. This is particularly advantageous in remote or challenging terrains where traditional monitoring methods may be impractical. Microfluidic devices offer high precision and sensitivity in the analysis of environmental samples. The ability to handle small volumes of samples allows for more efficient detection of contaminants, pollutants, and other critical parameters. Microfluidic platforms support multiplexing, allowing simultaneous analysis of multiple parameters in a single device. This capability is invaluable in comprehensive environmental monitoring, where various factors need to be assessed concurrently. Microfluidic systems consume significantly lower amounts of reagents compared to traditional methods. This not only contributes to cost savings but also aligns with sustainable practices by minimizing chemical waste. Microfluidic devices facilitate rapid analysis, enabling real-time monitoring of environmental conditions. This is crucial for timely intervention and decision-making in response to environmental changes or incidents.

Key Market Challenges

Costs and Scalability

One of the primary challenges facing the microfluidic components market is the associated costs. The intricate fabrication processes and the use of specialized materials contribute significantly to the overall expense of manufacturing these components. Microfabrication techniques, such as photolithography and soft lithography, require precision and expertise, leading to increased production costs. Furthermore, the demand for biocompatible materials in microfluidic devices, especially in applications related to healthcare and diagnostics, adds another layer of complexity. These materials must adhere to stringent quality standards, which can escalate manufacturing costs. As a result, companies operating in the microfluidic components market face the dilemma of balancing quality with cost-effectiveness.

Scalability is another critical issue affecting the global microfluidic components market. While microfluidic technologies excel in small-scale applications, translating these innovations into large-scale production remains a formidable task. The challenges in scaling up production processes include maintaining consistent quality, optimizing manufacturing efficiency, and ensuring cost-effectiveness. The intricacies of microfabrication, which are manageable at a smaller scale, become more complex when attempting to achieve mass production. Additionally, the transition from laboratory prototypes to commercial-scale manufacturing often requires substantial investments in equipment and infrastructure, posing a barrier to entry for some companies.

Key Market Trends

Technological Advancements

In the ever-evolving landscape of technology, one sector that has experienced significant growth is the microfluidic components market. Microfluidics, a field that involves the manipulation of small amounts of fluids, has gained momentum due to its diverse applications in various industries. The continuous influx of technological advancements has been a key driving force behind the expansion of the global microfluidic components market. One of the groundbreaking technological advancements in the microfluidics domain is the development of lab-on-a-chip (LOC) devices. These miniature systems integrate multiple laboratory functions onto a single chip, allowing for precise and efficient analysis of small fluid samples. This innovation has revolutionized diagnostics, making it possible to conduct complex tests with minimal sample volumes. The integration of 3D printing technology has opened new avenues for designing and manufacturing microfluidic devices. This method allows for the creation of intricate and customized structures that were previously challenging to achieve. The flexibility and cost-effectiveness of 3D printing have contributed to the growth of microfluidic components by simplifying the prototyping and production processes. Advancements in sensor technologies have led to the development of smart microfluidic devices equipped with sensors and actuators. These devices can provide real-time data, enabling precise control over fluid manipulation. This has found applications in fields such as point-of-care diagnostics, environmental monitoring, and drug delivery systems. In February 2024, researchers at RIT unveiled a microfluidic DNA processor, a "lab-on-chip" device that can both compute and read/write data stored within DNA. This innovative prototype enables artificial neural network computations using microfluidic solutions of engineered DNA molecules. The DNA processor not only performs mathematical and non-linear calculations typically expected from a conventional CPU but also offers networking capabilities to interact with other devices. This technological advancement represents a significant leap forward in DNA-based computing, showcasing the potential of microfluidic systems in enabling complex, data-driven applications. It exemplifies the ongoing progress in microfluidic technologies and their expanding role in cutting-edge computing and data processing.

The healthcare and life sciences sector has witnessed a profound impact from technological advancements in microfluidics. Miniaturized diagnostic tools, portable healthcare devices, and advancements in drug delivery systems have improved patient care and treatment outcomes. Biotechnological research has been accelerated by the integration of microfluidic components. The ability to conduct high-throughput screenings, analyze single cells, and perform DNA sequencing on a small scale has significantly enhanced the efficiency of biotechnology workflows. The development of portable and user-friendly microfluidic devices has paved the way for point-of-care diagnostics. These devices enable rapid and on-site testing, reducing the need for centralized laboratories and facilitating timely decision-making in healthcare settings.

Segmental Insights

Product Insights

Based on product, the Microneedles emerged as the fastest growing segment in the global market for Microfluidic Components during the forecast period. Microneedles offer a less invasive alternative to traditional injection-based drug delivery methods, providing a more comfortable and convenient experience for patients, especially those requiring frequent treatments such as insulin or vaccines. Advances in microneedle technology have enhanced their precision and control in drug delivery. New innovations, such as dissolving or coated microneedles, ensure more efficient delivery while minimizing the risk of infections or side effects. With a growing focus on global health, particularly in response to events like the COVID-19 pandemic, microneedles are emerging as a key solution for painless vaccine administration. They can deliver vaccines effectively without deep needle penetration, offering a breakthrough in immunization. Additionally, microneedles are self-administered by patients, reducing hospital visits and lowering healthcare costs, particularly in remote areas. Beyond drug delivery, microneedles are being increasingly utilized in diagnostics, such as glucose monitoring, and aesthetic treatments, further boosting their market potential. These advantages, coupled with the demand for more efficient, patient-friendly healthcare solutions, are driving the rapid growth of the microneedles segment in the microfluidic components market.

Industry Insights

Based on Industry, Healthcare emerged as the dominating segment in the global market for Microfluidic Components in 2024. Microfluidic technologies, including lab-on-a-chip (LOC) devices, are transforming diagnostics by providing real-time, rapid, and accurate testing, enabling earlier disease detection and improved treatment outcomes. These devices have gained widespread use in point-of-care (POC) diagnostics, particularly in remote areas. Microfluidics also facilitates the development of minimally invasive, patient-friendly solutions such as microneedles and micro-pumps, which are increasingly utilized in drug delivery. Additionally, microfluidic platforms support personalized medicine by enabling precise and controlled administration of therapeutic agents. With the growing prevalence of chronic conditions like diabetes and cardiovascular diseases, microfluidics is essential for continuous drug delivery systems, such as insulin pumps, providing more convenient and efficient therapies. Microfluidic technologies are also crucial in the development and delivery of biologics and vaccines, especially for rapid and effective vaccine distribution, as seen during the COVID-19 pandemic. As a result, the healthcare sector is driving the widespread adoption of microfluidic components, establishing it as the dominant industry in the market.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Microfluidic Components Market in 2024. North America boasts a robust healthcare system with substantial investments in medical research and technology. The region is home to leading pharmaceutical, biotechnology, and medical device companies that drive innovation and the widespread adoption of microfluidic technologies for diagnostics, drug delivery, and biologics development. Particularly in the U.S., significant investments in research and development have led to continuous advancements in microfluidics, with R&D spending rising by USD 72 billion in 2021 to USD 789 billion, with further increases expected. The region benefits from well-established regulatory standards that facilitate the development and commercialization of microfluidic solutions. Additionally, North America's strong venture capital ecosystem supports emerging companies in the microfluidic space, driving innovation and scalability. These combined factors have established North America as the dominant region in the microfluidic components market, making it a leader in advancing technology and expanding adoption, particularly within the healthcare industry.

Key Market Players

• Parker Hannifin Corporation
• IDEX Corporation
• Fluigent SA
• Staiger GmbH & Co. KG
• SMC Corporation
• Camozzi Automation Spa Societa Unipersonale
• Aignep s.p.a.
• FIM Valvole Srl
• Humphrey Products Corporation
• Dolomite Microfluidics
• Cellix Ltd.
• Christian Burkert GmbH & Co. KG

Report Scope:

In this report, the Global Microfluidic Components Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microfluidic Components Market, By Product:

• Valves (Solenoid Valves, Flow Control Valves, Check Valves, Shuttle Valves, Pressure Relief Valves, Proportional Valves, Other Valves)
• Flow and Pressure Controllers
• Flow and Pressure Sensors
• Micropumps
• Nozzles
• Microneedles
• Others

Microfluidic Components Market, By Industry:

• Oil & Gas
• Healthcare
• Aerospace & Defense
• Consumer Electronics
• Automotive
• Other Industries

Microfluidic Components Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Microfluidic Components Market.

Available Customizations:

Global Microfluidic Components market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Microfluidic Components Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Valves (Solenoid Valves, Flow Control Valves, Check Valves, Shuttle Valves, Pressure Relief Valves, Proportional Valves, Other Valves), Flow and Pressure Controllers, Flow and Pressure Sensors, Micropumps, Nozzles, Microneedles, Others)
  • 4.2.2. By Industry (Oil & Gas, Healthcare, Aerospace & Defense, Consumer Electronics, Automotive, Other Industries)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By Industry
  • 4.3.3. By Region

5. Asia Pacific Microfluidic Components Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Industry
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Microfluidic Components Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By Industry
  • 5.3.2. India Microfluidic Components Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By Industry
  • 5.3.3. Australia Microfluidic Components Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By Industry
  • 5.3.4. Japan Microfluidic Components Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By Industry
  • 5.3.5. South Korea Microfluidic Components Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By Industry

6. Europe Microfluidic Components Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Industry
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Microfluidic Components Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Industry
  • 6.3.2. Germany Microfluidic Components Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Industry
  • 6.3.3. Spain Microfluidic Components Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Industry
  • 6.3.4. Italy Microfluidic Components Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Industry
  • 6.3.5. United Kingdom Microfluidic Components Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Industry

7. North America Microfluidic Components Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Industry
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Microfluidic Components Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Industry
  • 7.3.2. Mexico Microfluidic Components Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Industry
  • 7.3.3. Canada Microfluidic Components Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Industry

8. South America Microfluidic Components Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Industry
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Microfluidic Components Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Industry
  • 8.3.2. Argentina Microfluidic Components Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Industry
  • 8.3.3. Colombia Microfluidic Components Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Industry

9. Middle East and Africa Microfluidic Components Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Industry
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Microfluidic Components Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Industry
  • 9.3.2. Saudi Arabia Microfluidic Components Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Industry
  • 9.3.3. UAE Microfluidic Components Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Industry
  • 9.3.4. Egypt Microfluidic Components Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Product
      • 9.3.4.2.2. By Industry

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Microfluidic Components Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Parker Hannifin Corporation
  • 14.1.1. Company Snapshot
  • 14.1.2. Product & Services
  • 14.1.3. Current Capacity Analysis
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. IDEX Corporation
• 14.3. Fluigent SA
• 14.4. Staiger GmbH & Co. KG
• 14.5. SMC Corporation
• 14.6. Camozzi Automation Spa Societa Unipersonale
• 14.7. Aignep s.p.a.
• 14.8. FIM Valvole Srl
• 14.9. Humphrey Products Corporation
• 14.10.Dolomite Microfluidics
• 14.11.Cellix Ltd.
• 14.12.Christian Burkert GmbH & Co. KG

15. Strategic Recommendations

16. About Us & Disclaimer